ACRP-CP CERTIFICATION EXAM
QUESTIONS AND ANSWERS
2024
1. What would be the first priority for an investigator when a subject wishes
to withdraw prematurely from the trial?: Try to obtain the subject's reason for
withdrawal.
2. CRO recently switched from paper CRF to an EDC system. The EDC system
must conform to the established requirements for: Validation
Accuracy
Reliability
Completeness
3. Part of a sponsor's responsibility pertaining to electronic trial data handling
is to: maintain an audit trail, data trail, and edit trail.
4. A research subject's responsibilities for study participation should be
described in the: ICF
5. What document would an investigator reference to learn more about the
previous clinical and nonclinical results of studies of the IP?: Investigators
brochure
6. During a multi site clinical study: whose responsibility is it to report subject
recruitment rate?: The CRA
7. An unconscious adult subject was enrolled in a study after obtaining
consent from an LAR: and protocol therapy was initiated. The subject
, showed significant improvement in his clinical condition: and regained
consciousness. The Investigator should inform the subject about the study
and: Obtain consent from the subject for the study
8. A site is in the start up phase of an industry sponsored phase 3 trial: and
has received IRB approval. The site can begin enrolling subjects after...: A
signed clinical trial agreement between the site and sponsor is in place.
9. A site is screening potential subjects for a study looking at mild cognitive
impairment. One of the inclusion criteria is a score of 25 or less on a
psychometric test: a research specific tool which measures cognitive
ability. Which of the following individuals can administer the psychometric
test to the potential subjects?: A research assistant who is certified to
administer the psychometric test
10. A research study: in which there is no intended clinical benefit to the
subject: is being submitted to the IRB. What benefit information should be
included in the ICF?: Wording indicating that there is no expected benefit should
be included
11. A CRA notices during an onsite visit that the date on IRB approval letter
for a protocol is prior to the effective date indicated on the cover page of the
protocol and the signatures of the investigator and sponsor. What should the
CRA do FIRST?: Confirm dates of initial receipt of the sponsor protocol and the
IRB submission dates.
12. In a multi arm: randomized clinical trial: one arm of the protocol was
terminated due to an increased risk of cancer in subjects. Who is responsible
for providing a written report to the IRB?: PI
13. Which of the following required elements should be included in a clinical
trial protocol?: Subject inclusion and exclusion criteria
14. Prior to archiving a study: documentation of IP destruction at the site
should be filed in the study files of the: PI and Sponsor
, 15. During a monitoring visit: what records would a CRA reference to verify
a subject's compliance to the study visit schedule and assessments?:
Electronic medical record
16. When considering participation in a study: the investigator should
determine if he...: Sees enough patients who would qualify for the study
17. New safety information has become available from the Sponsor about
the IP being used in a clinical trial. The investigator must: Submit a revised ICF
to the IRB noting the new safety information
18. Per ICH: an IRB must keep correspondence for at least how long after
the completion of a clinical trial?: 3 Years
19. When would an impartial witness be needed during the consent process
for an illiterate subject?: To observe the consent process
20. A study which seeks to determine the ideal dose and regimen of a new
IP to treat hypothyroidism is considered to be: Phase II
21. After completion of a study: the final trial close out monitoring report
prepared by the CRA should be filed in which of the following stakeholder
files?: The sponsors files
22. A blood sample collection is required to screen for bloodborne
pathogens before subject could be enrolled in a study. Where will subjects
find information of the procedures and any foreseeable risks or
inconveniences?: ICF
23. When should a research study involving human subjects be registered
in a publicly accessible database?: Before recruiting the first subject
24. In the case of an incapacitated subject: who should receive a copy of the
signed and dated ICF?: The subjects legally acceptable representative
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Davieacademia. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $18.49. You're not tied to anything after your purchase.